Grimes & Company, Inc. Bristol Myers Squibb CO Transaction History
Grimes & Company, Inc.
- $3.31 Billion
- Q2 2024
A detailed history of Grimes & Company, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Grimes & Company, Inc. holds 444,662 shares of BMY stock, worth $23.9 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
444,662
Previous 380,641
16.82%
Holding current value
$23.9 Million
Previous $20.6 Million
10.54%
% of portfolio
0.56%
Previous 0.64%
Shares
28 transactions
Others Institutions Holding BMY
# of Institutions
2,402Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.53 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.92 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.01 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.18 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $114B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...